Submit Deal

BRIGHTEDGE VENTURES

Summary

BrightEdge is an impact venture capital fund, meaning that the financial returns realized from investments are returned to the American Cancer Society.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 291 M

Avg. Deal Size£ 145 M

Market Context

Senior Management

Bob Crutchfield
Managing Director

Sort

23 May 2019|United States|Biotechnology

Target: FREENOME

Bidder: T. ROWE PRICE GROUP INC

17 Service Providers

3 Target | 14 Bidder

30 Dealmakers

8 Target | 24 Bidder

£ 126 M

Value

25 Jan 2023|United States|Medical Services

Target: PARADIGM INC

Bidder: F-PRIME CAPITAL

8 Service Providers

1 Target | 7 Bidder

11 Dealmakers

4 Target | 7 Bidder

£ 164 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy